Best Practice & Research Clinical Anaesthesiology
Volume 23, Issue 4 , Pages 487-496 , December 2009

How to weigh the current evidence for clinical practice

  • Andrew Padkin, BSc, MSc, MB.ChB, FRCA, MRCP (Consultant in Anaesthesia and Intensive Care Medicine)

      Affiliations

    • Corresponding Author InformationTel.: +44 1225 825056; Fax: +44 1225 825061.

References 

  1. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. New England Journal of Medicine. 2001;345:1359–1367
  2. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ (Canadian Medical Association Journal). 2009;180:821–827
  3. Finfer S, Delaney A. Tight glycemic control in critically ill adults. Journal of the American Medical Association. 2008;300:963–965
  4. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. New England Journal of Medicine. 2006;354:449–461
  5. Byar DP, Simon RM, Friedewald WT, et al. Randomized clinical trials. Perspectives on some recent ideas. New England Journal of Medicine. 1976;295:74–80
  6. Black N. Why we need observational studies to evaluate the effectiveness of health care. British Medical Journal. 1996;312:1215–1218
  7. Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Journal of the American Medical Association. 2001;285:1987–1991
  8. CONSORT Group . CONSORT. Transparent reporting of Trials. 15/6/2009. Available from: http://www.consort-statement.org/home
  9. Guyatt GH, Sackett DL, Cook DJ. Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group. Journal of the American Medical Association. 1993;270:2598–2601
  10. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine. 2009;360:1283–1297
  11. Kanji S, Buffie J, Hutton B, et al. Reliability of point-of-care testing for glucose measurement in critically ill adults. Critical Care Medicine. 2005;33:2778–2785
  12. Atkin SH, Dasmahapatra A, Jaker MA, et al. Fingerstick glucose determination in shock. Annals of Internal Medicine. 1991;114:1020–1024
  13. Critchell CD, Savarese V, Callahan A, et al. Accuracy of bedside capillary blood glucose measurements in critically ill patients. Intensive Care Medicine. 2007;33:2079–2084
  14. Petersen JR, Graves DF, Tacker DH, et al. Comparison of POCT and central laboratory blood glucose results using arterial, capillary, and venous samples from MICU patients on a tight glycemic protocol. Clinica Chimica Acta. 2008;396:10–13
  15. Kulkarni A, Saxena M, Price G, et al. Analysis of blood glucose measurements using capillary and arterial blood samples in intensive care patients. Intensive Care Medicine. 2005;31:142–145
  16. Slater-MacLean L, Cembrowski G, Chin D, et al. Accuracy of glycemic measurements in the critically ill. Diabetes Technology & Therapeutics. 2008;10:169–177
  17. Desachy A, Vuagnat AC, Ghazali AD, et al. Accuracy of bedside glucometry in critically ill patients: influence of clinical characteristics and perfusion index. Mayo Clinic Proceedings. 2008;83:400–405
  18. Sylvain HF, Pokorny ME, English SM, et al. Accuracy of fingerstick glucose values in shock patients. The American Journal of Critical Care. 1995;4:44–48
  19. U.S. Food and Drug Administration Office of Vitro Diagnostic Device Evaluation and Safety . FDA reminders for falsely elevated glucose readings from use of inappropriate test method. Available from: http://www.fda.gov/cdrh/oivd/news/glucosefalse.html2005;[cited 2009 22/05/09]
  20. Institute for Safe Medication Practices . Be aware of false glucose results with point-of-care testing. Available from: http://www.ismp.org/newsletters/acutecare/articles/20050908.asp2005;[cited 2009 22/5/2009]
  21. Korsatko S, Ellmerer M, Schaupp L, et al. Hypoglycaemic coma due to falsely high point-of-care glucose measurements in an ICU-patient with peritoneal dialysis: a critical incidence report. Intensive Care Medicine. 2009;35:571–572
  22. Cartier LJ, Leclerc P, Pouliot M, et al. Toxic levels of acetaminophen produce a major positive interference on Glucometer Elite and Accu-chek Advantage glucose meters. Clinical Chemistry. 1998;44:893–894
  23. Tang Z, Du X, Louie RF, Kost GJ. Effects of drugs on glucose measurements with handheld glucose meters and a portable glucose analyzer. American Journal of Clinical Pathology. 2000;113:75–86
  24. Finkielman JD, Oyen LJ, Afessa B. Agreement between bedside blood and plasma glucose measurement in the ICU setting. Chest. 2005;127:1749–1751
  25. Mann EA, Pidcoke HF, Salinas J, et al. Accuracy of glucometers should not be assumed. The American Journal of Critical Care. 2007;16:531–532author reply 532
  26. Mahoney JJ, Ellison JM. Assessing glucose monitor performance–a standardized approach. Diabetes Technology & Therapeutics. 2007;9:545–552
  27. Fahy BG, Coursin DB. Critical glucose control: the devil is in the details. Mayo Clinic Proceedings. 2008;83:394–397
  28. Eslami S, de Keizer NF, de Jonge E, et al. A systematic review on quality indicators for tight glycaemic control in critically ill patients: need for an unambiguous indicator reference subset. Critical Care. 2008;12:R139
  29. Vogelzang M, van der Horst IC, Nijsten MW. Hyperglycaemic index as a tool to assess glucose control: a retrospective study. Critical Care. 2004;8:R122–127
  30. Van Herpe T, De Brabanter J, Beullens M, et al. Glycemic penalty index for adequately assessing and comparing different blood glucose control algorithms. Critical Care. 2008;12:R24
  31. Vriesendorp TM, van Santen S, DeVries JH, et al. Predisposing factors for hypoglycemia in the intensive care unit. Critical Care Medicine. 2006;34:96–101
  32. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Critical Care Medicine. 2007;35:2262–2267
  33. Vriesendorp TM, DeVries JH, van Santen S, et al. Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Critical Care Medicine. 2006;34:2714–2718
  34. Mechanick JI, Handelsman Y, Bloomgarden ZT. Hypoglycemia in the intensive care unit. Current Opinion in Clinical Nutrition and Metabolic Care. 2007;10:193–196
  35. Vriesendorp TM, DeVries JH, Hoekstra JB. Hypoglycemia and strict glycemic control in critically ill patients. Current Opinion in Critical Care. 2008;14:397–402
  36. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine. 2008;358:125–139
  37. Egi M, Bellomo R, Stachowski E, et al. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology. 2006;105:244–252
  38. Wintergerst KA, Buckingham B, Gandrud L, et al. Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit. Pediatrics. 2006;118:173–179
  39. Ali NA, O'Brien JM, Dungan K, et al. Glucose variability and mortality in patients with sepsis. Critical Care Medicine. 2008;36:2316–2321
  40. Kovatchev BP, Otto E, Cox D, et al. Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care. 2006;29:2433–2438
  41. Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Critical Care Medicine. 2008;36:3008–3013
  42. Dossett LA, Cao H, Mowery NT, et al. Blood glucose variability is associated with mortality in the surgical intensive care unit. American Surgeon. 2008;74:679–685discussion 685
  43. Hirshberg E, Larsen G, Van Duker H. Alterations in glucose homeostasis in the pediatric intensive care unit: hyperglycemia and glucose variability are associated with increased mortality and morbidity. Pediatric Critical Care Medicine. 2008;9:361–366
  44. Meijering S, Corstjens AM, Tulleken JE, et al. Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature. Critical Care. 2006;10:R19
  45. Van Herpe T, De Moor B, Van den Berghe G. Towards closed-loop glycaemic control. Best Practice & Research. Clinical Anaesthesiology. 2009;23:69–80
  46. Pittas AG, Siegel RD, Lau J. Insulin therapy and in-hospital mortality in critically ill patients: systematic review and meta-analysis of randomized controlled trials. JPEN (Journal of Parenteral and Enteral Nutrition). 2006;30:164–172
  47. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. Journal of the American Medical Association. 2008;300:933–944
  48. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials. 1996;17:1–12
  49. Horton R. Common sense and figures: the rhetoric of validity in medicine. Bradford Hill Memorial Lecture 1999. Statistics in Medicine. 2000;19:3149–3164
  50. Rothwell PM. External validity of randomised controlled trials: “to whom do the results of this trial apply?”. Lancet. 2005;365:82–93
  51. Weiss NS, Koepsell TD, Psaty BM. Generalizability of the results of randomized trials. Archives of Internal Medicine. 2008;168:133–135
  52. Pitt B, Julian DG, Pocock SJ. Clinical trials in cardiology. London: Saunders; 1997;
  53. Meynaar IA, Dawson L, Tangkau PL, et al. Introduction and evaluation of a computerised insulin protocol. Intensive Care Medicine. 2007;33:591–596
  54. Preston S, Laver SR, Lloyd W, Padkin A. Introducing intensive insulin therapy: the nursing perspective. Nursing in Critical Care. 2006;11:75–79
  55. Goldberg PA, Siegel MD, Sherwin RS, et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004;27:461–467
  56. Clayton SB, Mazur JE, Condren S, et al. Evaluation of an intensive insulin protocol for septic patients in a medical intensive care unit. Critical Care Medicine. 2006;34:2974–2978
  57. Heiat A, Gross CP, Krumholz HM. Representation of the elderly, women, and minorities in heart failure clinical trials. Archives of Internal Medicine. 2002;162:1682–1688
  58. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. Journal of the American Medical Association. 2004;291:2720–2726
  59. Dhruva SS, Redberg RF. Variations between clinical trial participants and Medicare beneficiaries in evidence used for Medicare national coverage decisions. Archives of Internal Medicine. 2008;168:136–140
  60. Egi M, Bellomo R, Stachowski E, et al. Intensive insulin therapy in postoperative intensive care unit patients: a decision analysis. American Journal of Respiratory and Critical Care Medicine. 2006;173:407–413
  61. Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes. 2006;55:3151–3159
  62. Vanhorebeek I, Langouche L, Van den Berghe G. Tight blood glucose control: what is the evidence?. Critical Care Medicine. 2007;35:S496–502
  63. Marik PE, Varon J. Intensive insulin therapy in the ICU: is it now time to jump off the bandwagon?. Resuscitation. 2007;74:191–193
  64. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. Journal of Chronic Disease. 1967;20:637–648
  65. Zwarenstein M, Treweek S, Gagnier JJ, et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. British Medical Journal. 2008;337:a2390
  66. Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. Journal of the American Medical Association. 2003;290:1624–1632
  67. Van den Berghe G, Schetz M, Vlasselaers D, et al. Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target?. Journal of Clinical Endocrinology & Metabolism. 2009;94:3163–3170
  68. Bellomo R, Egi M. What is a NICE-SUGAR for patients in the intensive care unit?. Mayo Clinic Proceedings. 2009;84:400–402

PII: S1521-6896(09)00051-2

doi: 10.1016/j.bpa.2009.08.007

Best Practice & Research Clinical Anaesthesiology
Volume 23, Issue 4 , Pages 487-496 , December 2009

Article Tools